These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 36780493)

  • 21. Fluconazole compared with amphotericin B plus flucytosine for cryptococcal meningitis in AIDS. A randomized trial.
    Larsen RA; Leal MA; Chan LS
    Ann Intern Med; 1990 Aug; 113(3):183-7. PubMed ID: 2197908
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Short course amphotericin B with high dose fluconazole for HIV-associated cryptococcal meningitis.
    Muzoora CK; Kabanda T; Ortu G; Ssentamu J; Hearn P; Mwesigye J; Longley N; Jarvis JN; Jaffar S; Harrison TS
    J Infect; 2012 Jan; 64(1):76-81. PubMed ID: 22079502
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Short-course amphotericin B in addition to sertraline and fluconazole for treatment of HIV-associated cryptococcal meningitis in rural Tanzania.
    Katende A; Mbwanji G; Faini D; Nyuri A; Kalinjuma AV; Mnzava D; Hullsiek KH; Rhein J; Weisser M; Meya DB; Boulware DR; Letang E;
    Mycoses; 2019 Dec; 62(12):1127-1132. PubMed ID: 31461550
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Amphotericin B with or without flucytosine followed by fluconazole as primary therapy for cryptococcal meningitis in patients with AIDS.
    Jaruratanasirikul S
    Southeast Asian J Trop Med Public Health; 1996 Dec; 27(4):719-23. PubMed ID: 9253873
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Induction therapy with high-dose fluconazole plus flucytosine for human immunodeficiency virus-uninfected cryptococcal meningitis patients: Feasible or not?
    Zhao HZ; Cheng JH; Zhou LH; Luo Y; Zhu RS; Jiang YK; Wang X; Zhu LP
    Mycoses; 2023 Jan; 66(1):59-68. PubMed ID: 36111370
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of amphotericin B with fluconazole in the treatment of acute AIDS-associated cryptococcal meningitis. The NIAID Mycoses Study Group and the AIDS Clinical Trials Group.
    Saag MS; Powderly WG; Cloud GA; Robinson P; Grieco MH; Sharkey PK; Thompson SE; Sugar AM; Tuazon CU; Fisher JF
    N Engl J Med; 1992 Jan; 326(2):83-9. PubMed ID: 1727236
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Monitoring and impact of fluconazole serum and cerebrospinal fluid concentration in HIV-associated cryptococcal meningitis-infected patients.
    Manosuthi W; Chetchotisakd P; Nolen TL; Wallace D; Sungkanuparph S; Anekthananon T; Supparatpinyo K; Pappas PG; Larsen RA; Filler SG; Andes D;
    HIV Med; 2010 Apr; 11(4):276-81. PubMed ID: 20002501
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A phase II randomized trial of amphotericin B alone or combined with fluconazole in the treatment of HIV-associated cryptococcal meningitis.
    Pappas PG; Chetchotisakd P; Larsen RA; Manosuthi W; Morris MI; Anekthananon T; Sungkanuparph S; Supparatpinyo K; Nolen TL; Zimmer LO; Kendrick AS; Johnson P; Sobel JD; Filler SG
    Clin Infect Dis; 2009 Jun; 48(12):1775-83. PubMed ID: 19441980
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The efficacy of fluconazole 600 mg/day versus itraconazole 600 mg/day as consolidation therapy of cryptococcal meningitis in AIDS patients.
    Mootsikapun P; Chetchotisakd P; Anunnatsiri S; Choksawadphinyo K
    J Med Assoc Thai; 2003 Apr; 86(4):293-8. PubMed ID: 12757072
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fluconazole alone or combined with flucytosine for the treatment of AIDS-associated cryptococcal meningitis.
    Milefchik E; Leal MA; Haubrich R; Bozzette SA; Tilles JG; Leedom JM; McCutchan JA; Larsen RA
    Med Mycol; 2008 Jun; 46(4):393-5. PubMed ID: 18415850
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HIV-Associated Cryptococcal Meningitis Patients Treated with Amphotericin B Deoxycholate Plus Flucytosine under Routine Care Conditions in a Referral Center in São Paulo, Brazil.
    Vidal JE; de Albuquerque Moraes C; de Siqueira REB; Miranda NFB; Marcusso R; Boulware DR; de Oliveira ACP
    Mycopathologia; 2021 Mar; 186(1):93-102. PubMed ID: 33258083
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High dose fluconazole in salvage therapy for HIV-uninfected cryptococcal meningitis.
    Zhao HZ; Wang RY; Wang X; Jiang YK; Zhou LH; Cheng JH; Huang LP; Harrison TS; Zhu LP
    BMC Infect Dis; 2018 Dec; 18(1):643. PubMed ID: 30541454
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cryptococcal meningitis with atypical paradoxical inflammatory reactions after antifungal treatment in acquired immune deficiency syndrome: A case report.
    Samukawa S; Yoshimi R; Kojitani N; Uzawa Y; Takase-Minegishi K; Kirino Y; Soejima Y; Kato H; Nakajima H
    J Infect Chemother; 2023 Mar; 29(3):347-352. PubMed ID: 36384196
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combination antifungal therapies for HIV-associated cryptococcal meningitis: a randomised trial.
    Brouwer AE; Rajanuwong A; Chierakul W; Griffin GE; Larsen RA; White NJ; Harrison TS
    Lancet; 2004 May; 363(9423):1764-7. PubMed ID: 15172774
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Liposomal amphotericin B (AmBisome) compared with amphotericin B both followed by oral fluconazole in the treatment of AIDS-associated cryptococcal meningitis.
    Leenders AC; Reiss P; Portegies P; Clezy K; Hop WC; Hoy J; Borleffs JC; Allworth T; Kauffmann RH; Jones P; Kroon FP; Verbrugh HA; de Marie S
    AIDS; 1997 Oct; 11(12):1463-71. PubMed ID: 9342068
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [A clinical study of 26 cases of cryptococcal meningitis].
    Liu Z; Wang A; Li T; Qin S; Sheng R
    Zhonghua Nei Ke Za Zhi; 2002 Aug; 41(8):541-3. PubMed ID: 12421503
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An updated systematic review of HIV-associated cryptococcal meningitis treatment strategies.
    Shapiro AE; Tenforde MW; Chiller TM; Ford N; Rajasingham R
    HIV Med; 2023 Apr; 24(4):507-512. PubMed ID: 36123803
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Early versus delayed antiretroviral treatment in HIV-positive people with cryptococcal meningitis.
    Eshun-Wilson I; Okwen MP; Richardson M; Bicanic T
    Cochrane Database Syst Rev; 2018 Jul; 7(7):CD009012. PubMed ID: 30039850
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Triple therapy combined with ventriculoperitoneal shunts can improve neurological function and shorten hospitalization time in non-HIV cryptococcal meningitis patients with increased intracranial pressure.
    Li M; Liu J; Deng X; Gan Q; Wang Y; Xu X; Jiang Y; Peng F
    BMC Infect Dis; 2020 Nov; 20(1):844. PubMed ID: 33198666
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A controlled trial of fluconazole or amphotericin B to prevent relapse of cryptococcal meningitis in patients with the acquired immunodeficiency syndrome. The NIAID AIDS Clinical Trials Group and Mycoses Study Group.
    Powderly WG; Saag MS; Cloud GA; Robinson P; Meyer RD; Jacobson JM; Graybill JR; Sugar AM; McAuliffe VJ; Follansbee SE
    N Engl J Med; 1992 Mar; 326(12):793-8. PubMed ID: 1538722
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.